Vendor Intelligence Report: Oupeptide
Published 12 Nov 2026. 41-page investigative report on who is behind Oupeptide: corporate records, ownership, affiliate networks, and the vendor's lab-testing record. The first 4 pages are free to read on this page.
Researched and published by Finnrick Analytics. Reports draw on corporate records, affiliate-network analysis, and Finnrick's own laboratory testing record; vendors can challenge findings through the formal objections process at finnrick.com/vendor-support/objections.
Executive summary
Oupeptide is a product-by-product decision, not a storewide quality story. Across 196 Finnrick lab tests, Oupeptide has 133 pass / 63 fail, an overall pass rate of 68%. The record is uneven: Tirzepatide is the strongest live main-store choice, Retatrutide is second-tier, GHK-Cu tests best historically but is no longer a clean main-store SKU, and Tesamorelin is a clear weak spot. Several ratings compress under stricter grading.
The identity trail is less clean than the storefront presentation. The strongest corporate-name anchor is a Guangzhou 1688 profile, while the site's NY 38954 footer resolves to a Mississippi ZIP and legacy pages retain unrelated Washington placeholder content. This report does not infer absent expertise from unnamed staff; it shows what buyers cannot verify publicly: who controls sourcing, analytical review, QA and batch release.
The channel environment creates its own buyer risk. The report maps nine live Oupeptide-branded domains, fourteen agent personas, Discord and Telegram handoffs, and an operational Zen-Peptide link, without an authoritative channel list. Published Janoshik images function as static April 2025 evidence rather than current batch-release proof, and checkout exposed only LuckPay methods while the practical sales path points to WhatsApp negotiation. Rutgers and CETAF parasite-SEO pages show that the review environment is being manipulated, not merely discussed.
Inside the full report:
- Per-product pass/fail rates and methodology-divergence charts for all 11 tested products
- Timeline of the August 2026 catalog rebuild and removed SKUs
- Guangzhou 1688 corporate-anchor analysis, US-location mismatch and registry-search limitations
- Domain, agent, Discord/Telegram and Zen-Peptide network mapping
- COA chain-of-custody review of the five Janoshik reports and current catalog gaps
- Checkout, shipping, payment-channel and parasite-SEO evidence
Risk assessment
- Product-quality risk for specific compounds — high: High for Tesamorelin 38.68% (14 tests), TB-500 33.84% (5), BPC-157 45.72% (10), Cagrilintide 53.06% (4) and non-live CJC-1295 30.29% (3); KLOW has no Finnrick record; Tirzepatide 78.24% and Retatrutide 73.58% are better but not clean.
- Misrepresented US identity and manufacturing-credential risk — high: Site lists Street Name, NY 38954 / US, NY 38954; ZIP 38954 resolves to Sidon, Mississippi; no US entity was found in reviewed registries; the Guangzhou anchor is a body-care/collagen profile without public sterile-peptide GMP proof.
- Supply-chain and customs-opacity risk — high: Shipping page describes special-line export logistics, customs clearance before tracking, and 12-15 day delivery, while the refund policy describes a contradictory USPS/UPS domestic process.
- Brand-confusion and off-channel purchase risk — high: Nine live Oupeptide-branded domains, Zen-Peptide links, 14 agent personas, Discord/Telegram handoffs and two expired domains appear with no authorized-channel list, batch lookup or anti-counterfeit program.
- COA currency and chain-of-custody risk — high: Published Janoshik images are all batch 2025/04/02, analysed 2025-04-28; no published COA covers KLOW, CGL/Cagrilintide, BC/BPC-157 or TB/TB-500.
- Payment-channel risk — high: WooCommerce exposes only luckpay and luckpay_alcard; PayPal is installed but unavailable; the stated workflow moves buyers into WhatsApp quote-and-pay negotiation.
- Deceptive promotion/search-manipulation risk — medium: Parasite-SEO pages on Rutgers, CETAF and Peptides16 properties promote Oupeptide review/legit queries, with some pages removed and replaced within days.
- Customer-dispute and scam-report risk — medium: Gridinsoft rates oupeptide.com 8/100 as a Suspicious Shop; Reddit and forum leads describe peptide-seller scam disputes, though some are removed, indirect or do not match Oupeptide numbers.